Global Biosimilar of Remicade Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 115 pages | ID: GCD82774757EN
GlobalInfoResearch

Abstracts

Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. 

Scope of the Report:


The global Biosimilar of Remicade market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biosimilar of Remicade.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Biosimilar of Remicade market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimilar of Remicade market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Synthon Pharmaceuticals
• LG Life Sciences
• Novartis (Sandoz)
• Celltrion
• Biocon
• Hospira
• Merck Serono (Merck Group)
• Biogen idec Inc.
• Genentech (Roche Group)

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• 100mg/10ml
• 500mg/50ml

Market Segment by Applications, can be divided into

• Blood Disorders
• Oncology Diseases

Contents

1 BIOSIMILAR OF REMICADE MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilar of Remicade
1.2 Classification of Biosimilar of Remicade by Types
  1.2.1 Global Biosimilar of Remicade Revenue Comparison by Types (2017-2023)
  1.2.2 Global Biosimilar of Remicade Revenue Market Share by Types in 2017
  1.2.3 100mg/10ml
  1.2.4 500mg/50ml
1.3 Global Biosimilar of Remicade Market by Application
  1.3.1 Global Biosimilar of Remicade Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Blood Disorders
  1.3.3 Oncology Diseases
1.4 Global Biosimilar of Remicade Market by Regions
  1.4.1 Global Biosimilar of Remicade Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Biosimilar of Remicade Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Biosimilar of Remicade Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilar of Remicade Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Biosimilar of Remicade Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilar of Remicade Status and Prospect (2013-2023)
1.5 Global Market Size of Biosimilar of Remicade (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Synthon Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Biosimilar of Remicade Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Synthon Pharmaceuticals Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.2 LG Life Sciences
  2.2.1 Business Overview
  2.2.2 Biosimilar of Remicade Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 LG Life Sciences Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis (Sandoz)
  2.3.1 Business Overview
  2.3.2 Biosimilar of Remicade Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Novartis (Sandoz) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celltrion
  2.4.1 Business Overview
  2.4.2 Biosimilar of Remicade Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Celltrion Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biocon
  2.5.1 Business Overview
  2.5.2 Biosimilar of Remicade Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Biocon Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.6 Hospira
  2.6.1 Business Overview
  2.6.2 Biosimilar of Remicade Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Hospira Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck Serono (Merck Group)
  2.7.1 Business Overview
  2.7.2 Biosimilar of Remicade Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck Serono (Merck Group) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biogen idec Inc.
  2.8.1 Business Overview
  2.8.2 Biosimilar of Remicade Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Biogen idec Inc. Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
2.9 Genentech (Roche Group)
  2.9.1 Business Overview
  2.9.2 Biosimilar of Remicade Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Genentech (Roche Group) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BIOSIMILAR OF REMICADE MARKET COMPETITION, BY PLAYERS

3.1 Global Biosimilar of Remicade Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Biosimilar of Remicade Players Market Share
  3.2.2 Top 10 Biosimilar of Remicade Players Market Share
3.3 Market Competition Trend

4 GLOBAL BIOSIMILAR OF REMICADE MARKET SIZE BY REGIONS

4.1 Global Biosimilar of Remicade Revenue and Market Share by Regions
4.2 North America Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
4.5 South America Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilar of Remicade Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BIOSIMILAR OF REMICADE REVENUE BY COUNTRIES

5.1 North America Biosimilar of Remicade Revenue by Countries (2013-2018)
5.2 USA Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
5.3 Canada Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
5.4 Mexico Biosimilar of Remicade Revenue and Growth Rate (2013-2018)

6 EUROPE BIOSIMILAR OF REMICADE REVENUE BY COUNTRIES

6.1 Europe Biosimilar of Remicade Revenue by Countries (2013-2018)
6.2 Germany Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6.3 UK Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6.4 France Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6.5 Russia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
6.6 Italy Biosimilar of Remicade Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BIOSIMILAR OF REMICADE REVENUE BY COUNTRIES

7.1 Asia-Pacific Biosimilar of Remicade Revenue by Countries (2013-2018)
7.2 China Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7.3 Japan Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7.4 Korea Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7.5 India Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BIOSIMILAR OF REMICADE REVENUE BY COUNTRIES

8.1 South America Biosimilar of Remicade Revenue by Countries (2013-2018)
8.2 Brazil Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
8.3 Argentina Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
8.4 Colombia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BIOSIMILAR OF REMICADE BY COUNTRIES

9.1 Middle East and Africa Biosimilar of Remicade Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9.3 UAE Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9.4 Egypt Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
9.6 South Africa Biosimilar of Remicade Revenue and Growth Rate (2013-2018)

10 GLOBAL BIOSIMILAR OF REMICADE MARKET SEGMENT BY TYPE

10.1 Global Biosimilar of Remicade Revenue and Market Share by Type (2013-2018)
10.2 Global Biosimilar of Remicade Market Forecast by Type (2018-2023)
10.3 100mg/10ml Revenue Growth Rate (2013-2023)
10.4 500mg/50ml Revenue Growth Rate (2013-2023)

11 GLOBAL BIOSIMILAR OF REMICADE MARKET SEGMENT BY APPLICATION

11.1 Global Biosimilar of Remicade Revenue Market Share by Application (2013-2018)
11.2 Biosimilar of Remicade Market Forecast by Application (2018-2023)
11.3 Blood Disorders Revenue Growth (2013-2018)
11.4 Oncology Diseases Revenue Growth (2013-2018)

12 GLOBAL BIOSIMILAR OF REMICADE MARKET SIZE FORECAST (2018-2023)

12.1 Global Biosimilar of Remicade Market Size Forecast (2018-2023)
12.2 Global Biosimilar of Remicade Market Forecast by Regions (2018-2023)
12.3 North America Biosimilar of Remicade Revenue Market Forecast (2018-2023)
12.4 Europe Biosimilar of Remicade Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biosimilar of Remicade Revenue Market Forecast (2018-2023)
12.6 South America Biosimilar of Remicade Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biosimilar of Remicade Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Biosimilar of Remicade Picture
Table Product Specifications of Biosimilar of Remicade
Table Global Biosimilar of Remicade and Revenue (Million USD) Market Split by Product Type
Figure Global Biosimilar of Remicade Revenue Market Share by Types in 2017
Figure 100mg/10ml Picture
Figure 500mg/50ml Picture
Table Global Biosimilar of Remicade Revenue (Million USD) by Application (2013-2023)
Figure Biosimilar of Remicade Revenue Market Share by Applications in 2017
Figure Blood Disorders Picture
Figure Oncology Diseases Picture
Table Global Market Biosimilar of Remicade Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Biosimilar of Remicade Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Biosimilar of Remicade Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Biosimilar of Remicade Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Biosimilar of Remicade Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Biosimilar of Remicade Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Biosimilar of Remicade Revenue (Million USD) and Growth Rate (2013-2023)
Table Synthon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Synthon Pharmaceuticals Biosimilar of Remicade Type and Applications
Table Synthon Pharmaceuticals Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table LG Life Sciences Biosimilar of Remicade Type and Applications
Table LG Life Sciences Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis (Sandoz) Basic Information, Manufacturing Base and Competitors
Table Novartis (Sandoz) Biosimilar of Remicade Type and Applications
Table Novartis (Sandoz) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table Celltrion Basic Information, Manufacturing Base and Competitors
Table Celltrion Biosimilar of Remicade Type and Applications
Table Celltrion Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Biosimilar of Remicade Type and Applications
Table Biocon Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table Hospira Basic Information, Manufacturing Base and Competitors
Table Hospira Biosimilar of Remicade Type and Applications
Table Hospira Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Serono (Merck Group) Basic Information, Manufacturing Base and Competitors
Table Merck Serono (Merck Group) Biosimilar of Remicade Type and Applications
Table Merck Serono (Merck Group) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen idec Inc. Basic Information, Manufacturing Base and Competitors
Table Biogen idec Inc. Biosimilar of Remicade Type and Applications
Table Biogen idec Inc. Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table Genentech (Roche Group) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche Group) Biosimilar of Remicade Type and Applications
Table Genentech (Roche Group) Biosimilar of Remicade Revenue, Gross Margin and Market Share (2016-2017)
Table Global Biosimilar of Remicade Revenue (Million USD) by Players (2013-2018)
Table Global Biosimilar of Remicade Revenue Share by Players (2013-2018)
Figure Global Biosimilar of Remicade Revenue Share by Players in 2016
Figure Global Biosimilar of Remicade Revenue Share by Players in 2017
Figure Global Top 5 Players Biosimilar of Remicade Revenue Market Share in 2017
Figure Global Top 10 Players Biosimilar of Remicade Revenue Market Share in 2017
Figure Global Biosimilar of Remicade Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Biosimilar of Remicade Revenue (Million USD) by Regions (2013-2018)
Table Global Biosimilar of Remicade Revenue Market Share by Regions (2013-2018)
Figure Global Biosimilar of Remicade Revenue Market Share by Regions (2013-2018)
Figure Global Biosimilar of Remicade Revenue Market Share by Regions in 2017
Figure North America Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Europe Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure South America Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Table North America Biosimilar of Remicade Revenue by Countries (2013-2018)
Table North America Biosimilar of Remicade Revenue Market Share by Countries (2013-2018)
Figure North America Biosimilar of Remicade Revenue Market Share by Countries (2013-2018)
Figure North America Biosimilar of Remicade Revenue Market Share by Countries in 2017
Figure USA Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Canada Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Mexico Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Table Europe Biosimilar of Remicade Revenue (Million USD) by Countries (2013-2018)
Figure Europe Biosimilar of Remicade Revenue Market Share by Countries (2013-2018)
Figure Europe Biosimilar of Remicade Revenue Market Share by Countries in 2017
Figure Germany Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure UK Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure France Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Russia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Italy Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Biosimilar of Remicade Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Biosimilar of Remicade Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Biosimilar of Remicade Revenue Market Share by Countries in 2017
Figure China Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Japan Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Korea Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure India Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Table South America Biosimilar of Remicade Revenue by Countries (2013-2018)
Table South America Biosimilar of Remicade Revenue Market Share by Countries (2013-2018)
Figure South America Biosimilar of Remicade Revenue Market Share by Countries (2013-2018)
Figure South America Biosimilar of Remicade Revenue Market Share by Countries in 2017
Figure Brazil Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Argentina Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Colombia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Biosimilar of Remicade Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Biosimilar of Remicade Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biosimilar of Remicade Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biosimilar of Remicade Revenue Market Share by Countries in 2017
Figure Saudi Arabia Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure UAE Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Egypt Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure Nigeria Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Figure South Africa Biosimilar of Remicade Revenue and Growth Rate (2013-2018)
Table Global Biosimilar of Remicade Revenue (Million USD) by Type (2013-2018)
Table Global Biosimilar of Remicade Revenue Share by Type (2013-2018)
Figure Global Biosimilar of Remicade Revenue Share by Type (2013-2018)
Figure Global Biosimilar of Remicade Revenue Share by Type in 2017
Table Global Biosimilar of Remicade Revenue Forecast by Type (2018-2023)
Figure Global Biosimilar of Remicade Market Share Forecast by Type (2018-2023)
Figure Global 100mg/10ml Revenue Growth Rate (2013-2018)
Figure Global 500mg/50ml Revenue Growth Rate (2013-2018)
Table Global Biosimilar of Remicade Revenue by Application (2013-2018)
Table Global Biosimilar of Remicade Revenue Share by Application (2013-2018)
Figure Global Biosimilar of Remicade Revenue Share by Application (2013-2018)
Figure Global Biosimilar of Remicade Revenue Share by Application in 2017
Table Global Biosimilar of Remicade Revenue Forecast by Application (2018-2023)
Figure Global Biosimilar of Remicade Market Share Forecast by Application (2018-2023)
Figure Global Blood Disorders Revenue Growth Rate (2013-2018)
Figure Global Oncology Diseases Revenue Growth Rate (2013-2018)
Figure Global Biosimilar of Remicade Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Biosimilar of Remicade Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Biosimilar of Remicade Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Biosimilar of Remicade Revenue Market Forecast (2018-2023)
Figure Europe Biosimilar of Remicade Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Biosimilar of Remicade Revenue Market Forecast (2018-2023)
Figure South America Biosimilar of Remicade Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Biosimilar of Remicade Revenue Market Forecast (2018-2023)